Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients

A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome

(2014) Maegan E. Roberts et al.   GENETICS IN MEDICINE

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

(2013) Hans F A Vasen et al.   GUT

Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR

(2011) Megan P. Hitchins et al.   CANCER CELL

Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort†

(2011) MP Hitchins et al.   CLINICAL GENETICS

Immunosuppression and sebaceous tumors: A confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy

(2011) Megan N. Landis et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The cutaneous effects of post-transplant immunosuppression with cyclosporine in Muir-Torre syndrome

(2011) Emily A. Griffard et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Muir-Torre syndrome: Facts and controversies

(2010) Christine J. Ko   CLINICS IN DERMATOLOGY

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

(2008) Marjolijn J L Ligtenberg et al.   NATURE GENETICS